According to Zhitong Finance App, Kang Feng Bio-B (06922.HK) announced that Ningbo Shengjiekang Biotechnology Co., Ltd. (Ningbo Shengjiekang), a wholly-owned subsidiary of the company, will participate in the research project set up and managed by the Guangzhou National Laboratory with the First Affiliated Hospital of Guangzhou Medical University. Ningbo Shengjiekang recently signed a research cooperation agreement with Guangzhou National Laboratory and the First Affiliated Hospital of Guangzhou Medical University on the above projects.

Zhitongcaijing · 10/16 09:57
According to Zhitong Finance App, Kang Feng Bio-B (06922.HK) announced that Ningbo Shengjiekang Biotechnology Co., Ltd. (Ningbo Shengjiekang), a wholly-owned subsidiary of the company, will participate in the research project set up and managed by the Guangzhou National Laboratory with the First Affiliated Hospital of Guangzhou Medical University. Ningbo Shengjiekang recently signed a research cooperation agreement with Guangzhou National Laboratory and the First Affiliated Hospital of Guangzhou Medical University on the above projects.